XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
REVENUES:      
Revenues $ 2,231,262 $ 2,382,046 $ 2,259,126
Cost of Goods Sold 1,409,223 1,557,264 1,519,253
Gross profit 822,039 824,782 739,873
OPERATING EXPENSES:      
Selling, general and administrative 625,210 638,762 606,693
Research and development 87,495 88,615 85,344
Restructuring, strategic transaction and integration expenses 66,505 59,840 41,258
Change in fair value of contingent earn-out 0 (5,399) (16,247)
Total operating expenses 779,210 781,818 717,048
Income from operations 42,829 42,964 22,825
Interest Expense, Net (83,031) (95,753) (95,219)
OTHER EXPENSE, NET (232) (13,223) (5,905)
Gain (Loss) on Disposition of Business 44,792 0 0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total 4,358 (66,012) (78,299)
(Provision) benefit for income taxes (2,437) (51,676) 48,644
Income (Loss) from Continuing Operations before Equity Method Investments 1,921 (117,688) (29,655)
Income (Loss) from Equity Method Investments (1,189) 0 0
Net Income (Loss) $ 732 $ (117,688) $ (29,655)
Basic $ 0.03 $ (4.83) $ (1.23)
Diluted $ 0.03 $ (4.83) $ (1.23)
WEIGHTED AVERAGE NUMBER OF SHARES      
Basic (in shares) 24,640 24,388 24,091
Diluted (in shares) 24,904 24,388 24,091